YY/T 1249-2014Free prostate specific antigen quantitative labelling immunoassay kit (English PDF)
游离前列腺特异性抗原定量标记免疫分析试剂盒
This is a limited preview
Buy now to download the full PDF (15 pages)
Need quotation for your management?
Get a formal quotation for YY/T 1249-2014 in 30 minutes.
Issued by
NMPA
Level / Type
Industry · Recommended
Issue date
June 17, 2014
Implementation date
July 1, 2015
Scope
YY/T 1249-2014 is the English-translated version of 游离前列腺特异性抗原定量标记免疫分析试剂盒.
YY/T 1249-2014 is the Chinese pharmaceutical industry standard for the kit that measures free prostate specific antigen quantitatively by a labelled immunoassay.
It specifies the classification, the requirements, the test methods, the marks, the labels, the instructions and the rules for packaging, transport and storage, covering the appearance, the traceability of the calibrator, the accuracy, the linear range, the detection limit, the precision, the hook effect and the stability. Issued on 17 June 2014, it has applied since 1 July 2015.
Found what you need?
Document preview — YY/T 1249-2014
National Standard of the People's Republic of China
Issued by: National Medical Products Administration of the People's Republic of China
Contents
- 1 Scope4
- 2 Normative references4
- 3 Classification4
- 4 Requirements5
- 5 Test methods7
- 6 Marks, labels and instructions8
- 7 Packaging, transportation and storage10
- Bibliography11
Foreword
This Standard is drafted according to the rules specified in GB/T 1.1-2009.
1 Scope
This standard specifies the classification, requirements, test method, marks, labels, instructions, packaging, transportation, and storage of the free prostate specific antigen quantitative labelling immunoassay kit.
This standard is applicable to the kit which quantitatively determines the free prostate specific antigen (fPSA) by the principle of double antibody sandwich method (hereinafter referred to as. fPSA kit). It includes the immunoassay kit of quantitative determination of fPSA by using labelling methods such as enzyme labelling, (electrical) chemiluminescent labelling, (time resolution) fluorescence labelling AS the capture antibody; and using carriers such as microplates, pipes, magnetic particles, microbeads, and plastic beads AS the coated antibody. This standard does not apply to.
a) Reagent which is used to qualitatively or semi-quantitatively determine fPSA by colloidal gold or other methods (such as. test paper strip, etc.);
b) Various types of fPSA radio-immunity or IRMA kit labelled with 125I and other radioactive isotopes.
2 Normative references
The articles contained in the following documents have become part of this Document when they are quoted herein. For the dated documents so quoted, all the modifications (Including all corrections) or revisions made thereafter shall be applicable to this document.
GB/T 191 Packaging - Pictorial marking for handling of goods
3 Classification
According to different labelling method, fPSA kit can be divided into enzyme labelling fPSA kit, (electric) chemiluminescence labelling fPSA kit, (time-resolved) fluorescence labelling fPSA kit, etc.
4 Requirements
4.1 Appearance and physical examination
The kits shall be completed in components. The internal and external package shall be intact. The label shall be clear.
4.2 Linearity
Within the interval of 0.5 µg/L~10 µg/L, USE double logarithmic or other appropriate mathematical model for fitting. The linear correlation coefficient (r) of dose-response curve shall not be less than 0.9900.
4.3 Minimum detection limit
It shall not be higher than 0.20 µg/L.
4.4 Accuracy
Calibrator in the kit AND fPSA national (or international) standard materials with corresponding concentrations are tested at the same time. USE double logarithmic or other appropriate mathematical model for fitting.
4.5 Precision
4.5.1 Within-analysis precision
Coefficient of variation (CV) of measured results of control material of manual operation kit shall not be more than 15.0%; the coefficient of variation (CV) of measured results of control materials of full-automatic immune analysis system kit shall not be more than 8.0%.
4.6 The measured value of control materials
For the kit equipped with fixed-value control materials, its determination result shall be in the range specified by the kit.
4.7 Specificity
USE national (or international) standard materials of free prostate specific antigen taken AS the comparison materials. The determination result of national (or international) standard materials prostate specific antigen in this kit shall be consistent with its labelled ratio content.
4.8 Stability
4.8.1 Stability at the end of validity
The kit is preserved until the end of the validity under a stated condition. The measured results shall comply with provisions of 4.1, 4.2, 4.3, 4.4, 4.5.1 and 4.6.
5 Test methods
5.1 Appearance and physical examination
The visual inspection under the natural light shall be in compliance with the provisions of 4.1. The redissolving time of freeze-dried products is measured with timer.
5.2 Linearity
Dose - response curve linearity of the kit's calibrator shall be in compliance with the provisions of 4.4. For those kits not equipped with calibrator, USE fPSA national (or international) standard materials (or other high concentration sample); PREPARE the proper concentration points (generally no less than 5 points), according to the linear range specified by the kit instructions.
5.3 Minimum detection limit
Repeatedly TEST zero-calibrator (or diluent of sample) for not less than 10 times.
Calculate the average value (mean x) and standard deviation (SD) of reaction volume (A or RLU or CPS, etc.). SUBSTITUTE the reaction volume of (mean x + 2SD) into dose-response curve. Calculate the corresponding concentration value. It shall comply with provisions of 4.3.
5.5 Precision
5.5.1 Within-analysis precision
2 ~ 3 control materials are set up in different areas of dose-response curves. Within a same-analysis, repeatedly measure each control materials for not be less than 8 times.
The coefficient of variation (CV) of the measured results shall comply with provisions of 4.5.1.
5.6 The measured value of control materials
Control materials (usually 2-3) are set up in different areas of dose-response curves. The measured results of the kit shall comply with the provisions of 4.6.
5.7 Specificity
National (or international) standard materials of free prostate specific antigen (fPSA) AND national (or international) standard materials of prostate specific antigen (fPSA) are prepared to solutions with appropriate series of concentrations.
5.8 Stability
After the kit is preserved at conditions specified by provisions of 4.8.1, 4.8.2 or 4.8.3, MEASURE 4.1, 4.2, 4.3, 4.4, 4.5.1 and 4.6. The results shall comply with related provisions.
6 Marks, labels and instructions
6.1 Marks, labels of outer package of kit
It shall contain at least the following contents. […]
6.2 Marks and labels of each component package of kit
It shall contain at least the following contents. […]
6.3 Instructions of reagent (kit)
It shall generally contain the following contents. […]
7 Packaging, transportation and storage
7.1 Packaging
The kit shall be packed according to the requirements of product enterprise, and satisfy the requirements of GB/T 191.
7.2 Transportation
Reagent (kit) shall be transported according to the requirements of manufacturing enterprise. […]
......
This preview omits tables, figures, formulas and parts of the technical clauses. The complete document — 15 pages — is available in the English PDF.
Referenced standards
Normative references
Similar standards
How to Download YY/T 1249-2014
- 1
Add to cart
Click "Download PDF" on this page and choose "Buy this standard". You can add more standards before checkout.
- 2
Checkout
Enter your email and billing details. Payment is processed securely by Stripe (cards or bank transfer). Prefer bank details? Request a quotation (min. order $300).
- 3
Instant delivery (0–9 sec)
Delivery is automatic: within seconds of payment you'll receive an email with a secure download link. The link stays valid for 72 hours.
- 4
Invoice included
A tax invoice is attached to the confirmation email. Need a custom invoice? Contact us.
Related Standards
GB/T 191-2025 — Graphical symbols marking for handling and storage of packages
YY/T 0297-2026 — General requirements for clinical investigation of medical devices
YY/T 0479-2026 — Medical diagnostic X-ray tube assemblies and X-ray source assemblies - Determination of maximum symmetric radiation field
Secure payment via Stripe
Payments accepted
YY/T 1249-2014
$125.00